The association between fibrinogen reactivity to mental stress and high-sensitivity cardiac troponin T in healthy adults  by Lazzarino, Antonio Ivan et al.
Psychoneuroendocrinology (2015) 59, 37—48
Available online at www.sciencedirect.com
ScienceDirect
journa l homepage: www.e lsev ier .com/ locate /psyneuen
The association between ﬁbrinogen
reactivity to mental stress and
high-sensitivity cardiac troponin T
in healthy adults
Antonio Ivan Lazzarinoa,∗, Mark Hamera, David Gazeb,
Paul Collinsonb, Ann Rumleyc, Gordon Lowec, Andrew Steptoea
a Department of Epidemiology and Public Health, University College London, 1-19 Torrington Place, London
WC1E 6BT, United Kingdom
b Chemical Pathology, Clinical Blood Sciences, St George’s Healthcare NHS Trust, Blackshaw Road, Tooting,
London SW17 0QT, United Kingdom
c Institute of Cardiovascular and Medical Sciences, University of Glasgow, Glasgow G12 8TA, United Kingdom
Received 28 January 2015; received in revised form 6 May 2015; accepted 6 May 2015
KEYWORDS
Stress;
Psychological;
Fibrinogen;
Troponin T;
Atherosclerosis;
Allostasis
Summary
Background: Plasma ﬁbrinogen is considered as a positive mediator between mental stress and
cardiovascular disease because it is an acute-phase protein released in response to mental
stress and a coagulation factor. However those three factors have never been studied together
within a single integrated framework, using cardiac troponin T as a marker of cardiovascular
risk.
Methods: 491 disease-free men and women aged 53—76 were tested for ﬁbrinogen levels before,
immediately after, and following recovery from standardized mental stress tasks. We measured
plasma cardiac troponin T using a high-sensitivity assay (HS-CTnT) and coronary calciﬁcation
using electron-beam dual-source computed tomography.
Results: The average ﬁbrinogen concentration increased by 5.1% (s.d. = 7.3) in response to
stress and then tended to return to baseline values. People with higher baseline ﬁbrinogen
values had smaller increases (blunted responses) following the stress task (P = 0.001), and peo-
ple with higher stress responses showed better recovery (P < 0.001). In unadjusted analyses,
higher baseline ﬁbrinogen was associated with higher chances of having detectable HS-CTnT
(P = 0.072) but, conversely, higher ﬁbrinogen response was associated with lower chances of
having detectable HS-CTnT (P = 0.007). The adjustment for clinical, inﬂammatory, and haemo-
static factors, as well as for coronary calciﬁcation eliminated the effect of baseline ﬁbrinogen,
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whereas the negative association
the odds of detectable HS-CTnT h
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. Introduction
ental stress is a recognized risk factor for cardiovascular
isease (CVD) in acute conditions, when sudden stressful
vents trigger acute CVD events, as well as in chronic con-
itions, when poor adaptation to recurrent daily stressors
roduces a pathophysiological substratum for CVD (Brotman
t al., 2007; Steptoe and Kivimäki, 2012; Surtees et al.,
008). Although the mechanisms underlying these associa-
ions have not been completely clariﬁed, proinﬂammatory
actors, cortisol levels, heart rate variability, and haemo-
tatic processes have been identiﬁed as key mediators
Dimsdale, 2008; Lazzarino et al., 2013; Steptoe and Vögele,
991).
Fibrinogen is a plasma protein produced by the liver
nd is a major coagulation factor. It is a positive acute-
hase reactant protein, i.e. its concentration increases with
nﬂammation, and it is traditionally considered as a risk
actor for CVD because it promotes formation of thrombus
Lowe et al., 2004; Stulnig, 2013).
A number of studies have found positive associations
etween mental stress and plasma ﬁbrinogen concentration
Brunner et al., 1996; Kittel et al., 2002; Steptoe et al.,
003, 2004; Von Känel et al., 2001; Wirtz et al., 2008, 2009).
hese include large-scale population surveys linking single
easurements of plasma ﬁbrinogen with questionnaire-
ased self-reported levels of chronic stress, and more
ocused psychophysiological studies that have measured ﬁb-
inogen secretion in response to acute mental stress in
aboratory-based experimental settings. Regardless of the
tudy design and the reference population, higher stress
as associated with higher ﬁbrinogen plasma concentration
Brunner et al., 1996; Kittel et al., 2002; Steptoe et al.,
003, 2004; Von Känel et al., 2001; Wirtz et al., 2008, 2009).
The pathway linking mental stress, ﬁbrinogen, and CVD
ight therefore appear to be deﬁned: the greater the stress
or poor adaptation to stress), the higher the ﬁbrinogen, and
he greater the occurrence of CVD (Austin et al., 2013).
Nevertheless this causal sequence has not been com-
letely disentangled because the three components have
ever been studied together in a single framework. Instead,
he current literature is made of two separate groups of
tudies: one considering heightened ﬁbrinogen as a func-
ion of mental stress, and another set considering it as a
isk factor for CVD. This separation inevitably dictates a
onophasic approach to a phenomenon which may rather
e better described within an integrated multiphasic frame-
ork due to the complex dynamics of ﬁbrinogen metabolism
nd of coagulation pathways in general.
The notion of allostasis has drawn attention to the com-
lex system of neuroendocrine responses to environmental
r
r
T
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between ﬁbrinogen response and HS-CTnT remained robust:
alved for each 10% increase in ﬁbrinogen concentration due to
I = 0.30—0.82).
sponses to mental stress are associated with lower likelihood of
in T plasma concentration. A more dynamic ﬁbrinogen response
ardiovascular health.
y Elsevier Ltd. This is an open access article under the CC BY
.org/licenses/by/4.0/).
hallenges that is characteristic of living organisms. It has
een conceptualized as the process through which organ-
sms actively adjust to both predictable and unpredictable
xternal events through the anabolism and catabolism of
ediators, i.e. the way in which they maintain stabil-
ty through change (McEwen and Wingﬁeld, 2003). From
his perspective, serious pathophysiology may occur when
hronic overload resulting from sustained stress stimulates
rolonged allostatic actions that in the long term lose
heir effectiveness and ability to respond (McEwen and
ingﬁeld, 2010). The allostatic model suggests that sus-
ained load is characterized by changes in the morphology
f responses that are manifest in chronically heightened
asal levels, inadequate biological responses (blunted stress
eactivity), and impaired post-stress recovery (McEwen,
998).
We have recently used cardiac Troponin T (CTnT) as
marker of CVD risk in conjunction with mental stress
Lazzarino et al., 2013). CTnT is a plasma protein routinely
ested for the diagnosis of acute myocardial infarction (AMI),
ince it is a marker of myocardial cell damage (Thygesen
t al., 2007). In clinical settings, CTnT is measured using
tandard assays that have a lower detection limit of 10 ng/L
Wallace et al., 2006) and a diagnostic threshold of 35 ng/L
Thygesen et al., 2007; Wallace et al., 2006). However,
igh-sensitivity assays have recently been developed (HS-
TnT) with a lower detection limit of 3 ng/L (Collinson,
011; Collinson et al., 2012; Giannitsis et al., 2010). In
ealthy people not fulﬁlling any diagnostic criterion for AMI,
reater HS-CTnT is associated with greater incidence of AMI,
ther structural and functional heart diseases, cardiovascu-
ar mortality, and all-cause mortality, and can be therefore
onsidered the most proximal sentinel marker of heart dis-
ase (deFilippi et al., 2010; De Lemos et al., 2010). We have
hown that dysregulated response to mental stress — marked
sing salivary cortisol release in response to mental stress
was associated with detectable plasma levels of HS-CTnT.
f HS-CTnT is a good marker of CVD risk linked to mental
tress, it may therefore be a valid outcome in the study of
brinogen release in response to mental stress (Lazzarino
t al., 2013).
Fibrinogen can be considered as an important component
f the network of mediators relevant to cardiovascular
llostasis because of its association with both mental
tress and CVD, and because of its role within the coag-
lation system and in inﬂammation. Therefore we aimed
o study the associations between basal ﬁbrinogen, ﬁb-
inogen secretion in response to stress tasks, ﬁbrinogen
ecovery from stress, and high-sensitivity cardiac troponin
(as a marker of CVD risk) within a single integrated
ramework.
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2Fibrinogen reactivity to mental stress and risk of heart disea
2. Methods
2.1. Study design
Our study involved participants drawn from the Whitehall
II epidemiological cohort (Marmot et al., 1991) for psy-
chophysiological testing between 2006 and 2008 (Hamer
et al., 2010). The criteria for entry into the study included
no history or objective signs of clinical or subclinical CVD,
no previous diagnosis or treatment for hypertension, inﬂam-
matory diseases, allergies, or kidney disease. CVD was
deﬁned as prior myocardial infarction, stable or unstable
angina, revascularization procedure, heart failure, transient
ischaemic attack, stroke, or electrocardiographic abnor-
malities (resting 12-lead electrocardiograms were taken).
This information was conﬁrmed by a telephone interview
and veriﬁed from clinical data collected from the previ-
ous seven phases of the Whitehall II study. Volunteers were
of white European origin, aged 53—76 years, and 56.5%
were in full-time employment. Selection was stratiﬁed by
grade of employment (current or most recent) to include
higher and lower socioeconomic status participants. From
the initially invited participants (n = 1169), 27.6% were not
eligible (mainly because of prescribed medications) and
25.9% declined to take part. Participants were prohibited
from using any anti-histamine or anti-inﬂammatory medi-
cation 7 days before testing and were rescheduled if they
reported colds or other infections on the day of testing.
Participants gave full informed consent to participate in
the study and ethical approval was obtained from the UCLH
committee on the Ethics of Human Research.
2.2. Data collection
We carried out psychophysiological stress testing in either
the morning or afternoon in a light temperature-controlled
laboratory. This procedure was based on a protocol pre-
viously used in this laboratory (Steptoe et al., 2002).
Participants were instructed to refrain from drinking caf-
feinated beverages or smoking for at least 2 h before the
study and not to have performed vigorous physical activ-
ity or consumed alcohol the previous evening. Venipuncture
was performed using a butterﬂy needle that was inserted
before the beginning of the session and removed after the
end of it. After a 30min rest period from needle insertion,
baseline blood pressure (using an automated UA-779 digi-
tal monitor) was taken as well as saliva and blood samples.
Two behavioural tasks, designed to induce mental stress,
were then administered in random order. The tasks were a
computerized version of the Stroop task and mirror tracing,
both of which have been used extensively in psychophys-
iological research (Steptoe et al., 2002). The tasks each
lasted for 5min. Saliva and blood samples were then col-
lected immediately and at 45min after the tasks. The saliva
samples were collected using Salivettes (Sarsted, Leicester,
UK), which were stored at −30 ◦C until analysis. Levels of
cortisol were assessed using a time resolved immunoassay
with ﬂuorescence detection, at the University of Dresden.
The intra- and inter-assay coefﬁcients of variation were less
than 8%. We assayed plasma IL-6 using a Quantikine® high
sensitivity two-site enzyme-linked immunosorbent assay
W
i
c39
ELISA) from R&D Systems (Oxford, UK). The sensitivity of
he assay ranged from 0.016 to 0.110 pg/ml and the intra
nd inter assay coefﬁcients of variation (CV) were 7.3%
nd 7.7% respectively. C-reactive protein (CRP) was mea-
ured using high-sensitivity ELISA (R&D Systems, Oxford,
K; CVs <8%). Monocyte chemotactic protein-1 (MCP-1) was
ssayed using the Magnetic Luminex Performance Assay
uman CCL2/MCP-1 multiplexed IL-1RA kit (R&D Systems®)
ead on a Luminex 200 (Bio-Rad®) with a CV <8%. Von
illebrand factor (vWF) was determined using a double
andwiched antibody enzyme-linked immunoassay (Dako-
ytomation Ltd., Cambridge, UK; CVs <5%) and ﬁbrinogen
y an automated Clauss assay in a MDA-180 coagulometer
Organon Teknika, Cambridge, UK) using the manufacturer’s
eagents and the International ﬁbrinogen standard (inter-
nd intra-individual CV is 8%) (Gaffney and Wong, 1992).
We measured cardiac troponin T plasma concentration at
5min after the end of the mental stress task using a highly
ensitive assay on an automated platform (Elecsys 2010 Tro-
onin T hs STAT, Roche Diagnostics). The lower detection
imit was 3 ng/L with a reported 99th percentile value in
pparently healthy individuals of 13.5 ng/L, at which the
nter- and intra-individual CV is 9%, conﬁrmed by in-house
tudies (Collinson, 2011; Collinson et al., 2012; Giannitsis
t al., 2010).
We assessed coronary artery calciﬁcation (CAC) in sep-
rate sessions using electron beam computed tomography
GE Imatron C-150, San Francisco, CA, USA) as previously
escribed (Anand et al., 2007). In brief, 40 contiguous 3mm
lices were obtained during a single breath-hold starting at
he carina and proceeding to the level of the diaphragm.
can time was 100ms/slice, synchronized to 40% of the
—R interval. Agatston and volumetric calcium scores were
alculated to quantify the extent of CAC by a single expe-
ienced investigator blinded to the psychophysiological and
linical data on an Aquarius workstation (TeraRecon Inc.,
an Mateo, CA, USA). Since calciﬁed volume was very highly
orrelated with Agatston score (Spearman’s rho = 0.99), we
resent data for Agatston score only.
Participants reported current smoking levels, weekly
lcohol intake (units per week), employment grade (as
marker of social position), and hours of moderate or
igorous physical activity per week. We measured height
nd weight in light clothing for the calculation of body
ass index (BMI) as kg/m2. Fasting blood samples were
aken during a separate clinical assessment. Total and
igh-density lipoprotein (HDL) cholesterol and triglycerides
ere measured within 72 h in serum stored at 4 ◦C using
nzymatic colorimetric methods. Low-density lipopro-
ein (LDL) cholesterol was derived using the Friedewald
quation (Warnick et al., 1990). Glucose homeosta-
is was assessed from glycated haemoglobin (HbA1C)
oncentration, assayed using boronate afﬁnity chromatog-
aphy, a combination of boronate afﬁnity and liquid
hromatography.
.3. Data analysise checked the data for missing, inconsistent, and duplicate
nformation, as well as normality and digit preference for
ontinuous variables.
4 A.I. Lazzarino et al.
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3. Results
A total of 543 people participated in the study, but 52 (9.6%)
had missing information for HS-CTnT or ﬁbrinogen due to
insufﬁcient blood samples and were therefore removed.
The ﬁnal analytic sample comprised 491 disease-free par-
ticipants aged 62.9 years on average (standard deviation
[s.d.] = 5.7) of whom 54.1% were men. The excluded par-
ticipants did not differ signiﬁcantly from the main sample in
any covariates. The mean ﬁbrinogen concentration at base-
line was 314.1mg/dL (s.d. = 61.6), and on average increased
to the value of 330.1mg/dL (s.d. = 65.9) in response to
the stress task, and then decreased during the recov-
ery period to the mean value of 321.9mg/dL (s.d. = 65.0)
measured at 45min post task. There was considerable
inter-individual variation in ﬁbrinogen response and recov-
ery: the average ﬁbrinogen increase in response to the
stress tasks was 5.1% (s.d. = 7.3) with values ranging from
−30.5% to +57.6% (therefore for some individuals ﬁbrino-
gen plasma concentration decreased in response to the
stress tasks), and the average decrease in ﬁbrinogen dur-
ing the recovery period was 2.3% (s.d. = 7.8) with values
ranging from −68.5% to +23.1% (therefore for some indi-
viduals ﬁbrinogen plasma concentration increased during
the resting period). The prevalence of detectable levels of
HS-CTnT concentrations was 17.1% (95% conﬁdence interval
[CI] = 13.8%—20.5%).
In unadjusted analysis, people with detectable levels of
HS-CTnT appeared to have on average higher levels of base-
line ﬁbrinogen and ﬂatter proﬁle to the mental stress test,
i.e. blunted response and slower recovery (Fig. 1).
Table 1 describes the sample according to baseline ﬁb-
rinogen. People with higher ﬁbrinogen tended to be older, of
lower socio-economic status as deﬁned by grade of employ-
ment, were more likely to be female, smoker, and low
alcohol consumers, and also tended to have higher levels of
clinical and inﬂammatory factors such as BMI, blood pres-
sure, glycated haemoglobin, LDL, total cholesterol, CRP,
Figure 1 Mean concentration of ﬁbrinogen in the peripheral
blood plasma, measured at baseline (before the stress task),
immediately after the stress task (response values), and follow-
ing a 45min rest period (recovery) in people with (n = 407) and0
We quantiﬁed the ﬁbrinogen response to stress as the pro-
ortional increase in ﬁbrinogen plasma concentration after
he stress task ([immediate-post-task minus pre-task]/pre-
ask). Similarly, we quantiﬁed the ﬁbrinogen recovery
rom stress as the proportional decrease in ﬁbrinogen
fter the stress task ([immediate-post-task minus 45min-
ost-task]/immediate-post-task). Agatston CAC score had
right-skewed distribution and for some analyses was
ransformed into an ordered categorical variable with four
ategories (cut-offs at 0, 100, and 400).
We conducted bivariate analyses and calculated P val-
es using the likelihood ratio test. We then used three
eparate sets of multiple logistic regression models to exam-
ne the association between detectable HS-CTnT (outcome)
ith either baseline ﬁbrinogen or ﬁbrinogen stress response
r ﬁbrinogen recovery (alternative exposure variables).
ibrinogen response or recovery may differ according to
aseline levels, so this parameter was included as a covari-
te when they were the exposure variable. We also adjusted
or demographics such as age, gender, and employment
rade, and for health behaviours such as smoking and alcohol
ntake because they are related to CVD and may confound
he association between ﬁbrinogen and CVD. We also took
nto account clinical variables that are known to be linked
ith CVD such as BMI, blood pressure, glycated haemoglobin
HbA1c), triglycerides, LDL, and total cholesterol/HDL ratio.
oreover, we adjusted for baseline and response values of
irculating markers of inﬂammation and endothelial dys-
unction such as CRP, cortisol, IL-6, vWF, and MCP-1 to
ccount for vascular inﬂammation and endothelial dysfunc-
ion. Finally, we adjusted for Agatston CAC score to examine
hether the association between ﬁbrinogen and HS-CTnT
as independent of underlying coronary atherosclerosis. We
valuated the extent of multicollinearity among covariates
y computing one-to-one correlation coefﬁcients and by
xamining variance inﬂation factors (VIF) (‘‘Regression with
tata Web Book: Chapter 2 — Regression Diagnostics,’’ n.d.).
We performed several sensitivity analyses: we considered
tress response and recovery as absolute changes in ﬁb-
inogen concentration rather than relative (the Spearman’s
ho coefﬁcient of correlation between the two approaches
as 0.98 for stress response and 0.99 for stress recovery);
e adjusted for CAC using a continuous natural loga-
ithmic scale (before the log-transformation, zero values
ere recoded to values equal to the half of the small-
st value in the dataset); we repeated the analyses of
tress responses and recovery without adjusting for baseline
alues of ﬁbrinogen; we restricted the analysis to partic-
pants with no CAC; after having ﬁtted the ﬁnal models
e carried out a backward stepwise estimation to elim-
nate unnecessary covariates (P value for retention = 0.05
r less); given the elevated number of undetectable val-
es for HS-CTnT, we have transformed that measure into
n ordered categorical variable scoring zero for unde-
ectable levels (<3 ng/L), one for detectable levels up to
.63 ng/L (median value for detectable levels), and two for
etectable levels above 5.63 ng/L, and used multinomial
ogistic regression and linear regression instead of logistic
egression.
Additional analyses involved blood pressure response and
eart rate response as possible determinants of HS-CTnT
etection.
without (n = 84) detectable levels of HS-CTnT peripheral blood
plasma concentration, for 491 disease-free participants drawn
from the Whitehall II epidemiological cohort between 2006 and
2008 in United Kingdom.
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Table 1 Characteristics of the study sample by tertiles of plasma ﬁbrinogen concentration measured at baseline, for 491
disease-free participants drawn from the Whitehall II epidemiological cohort between 2006 and 2008 in United Kingdom.
Factor and category Tertiles of plasma ﬁbrinogen at baseline P
Lowest Medium Highest
Age (mean years± s.d.) 62.4 ±5.2 62.9 ±5.6 63.6 ±6.2 0.001
Male (%) 66.1 50.6 46.6 <0.001
Latest grade of employment (%)
Higher 42.5 40.7 33.5 <0.001
Intermediate 42.5 39.0 35.8
Lower 14.9 20.3 30.7
Current smoker (%) 3.4 4.1 9.1 <0.001
Alcohol consumption (%)
No alcohol 9.8 15.7 21.6 0.005
Below recommended levels 74.7 73.3 65.3
Above recommended levels 15.5 11.0 13.1
Hours of physical activity per week (%)
<1 h 22.1 24.1 24.4 0.559
1—4h 29.7 36.7 30.2
5—7h 23.8 21.7 22.7
>7 h 24.4 17.5 22.7
Body mass index (mean kg/m2 ± s.d.) 24.6 ±3.2 25.6 ±3.8 27.2 ±4.3 <0.001
Systolic blood pressure (mean mmHg± s.d.) 127.0 ±14.7 130.4 ±16.4 129.6 ±16.3 0.123
Diastolic blood pressure (mean mmHg± s.d.) 68.2 ±8.2 70.5 ±8.7 70.5 ±9.2 0.015
Glycated haemoglobin (mean %± s.d.) 5.4 ±0.6 5.5 ±0.4 5.5 ±0.4 0.001
Triglycerides (median g/L± IQR) 1.2 ±0.8 1.2 ±1.0 1.2 ±0.7 0.761
HDL (mean mmol/L± s.d.) 1.7 ±0.5 1.7 ±0.5 1.7 ±0.5 0.661
LDL (mean mmol/L± s.d.) 2.9 ±0.8 3.0 ±0.8 3.1 ±1.0 0.013
Total cholesterol (mean mmol/L± s.d.) 5.2 ±0.9 5.3 ±0.9 5.4 ±1.0 0.043
Total cholesterol/HDL ratio (mean± s.d) 3.3 ±1.0 3.4 ±1.1 3.5 ±1.2 0.074
C-reactive protein (median mg/L± IQR) 0.6 ±0.7 1.0 ±1.1 1.7 ±2.2 <0.001
Salivary cortisol (mean nmol/L± s.d.) 6.8 ±5.1 6.4 ±3.8 6.3 ±4.0 0.566
IL-6 (median pg/ml± IQR) 0.9 ±0.5 1.1 ±0.8 1.4 ±1.1 <0.001
Von Willebrand factor (mean %± s.d.) 96.3 ±35.3 102.9 ±36.9 114.4 ±44.1 0.001
MCP-1 (median pg/mL± IQR) 134.8 ±58.7 138.4 ±54.5 141.8 ±61.6 0.492
Fibrinogen (mean mg/dL± s.d.) 251.8 ±24.7 308.7 ±13.2 380.9 ±46.5
Salivary cortisol response (mean %
increase± s.d.)
15.1 ±65.4 16.7 ±53.5 17.7 ±60.2 0.520
IL-6 response (mean % increase± s.d.) 46.2 ±74.3 34.7 ±44.9 35.5 ±59.8 0.212
Von Willebrand factor response (mean %
increase± s.d.)
7.1 ±22.6 4.3 ±20.7 3.7 ±18.5 0.554
MCP-1 response (mean % increase± s.d.) 8.6 ±24.5 9.2 ±23.8 5.8 ±20.6 0.325
Fibrinogen response (mean % increase± s.d.) 6.6 ±8.0 4.5 ±7.2 4.3 ±6.5 0.001
Fibrinogen recovery (mean % decrease± s.d.) 2.6 ±8.5 2.3 ±7.6 2.0 ±7.5 0.363
Agatston coronary calcium score
(%)
None 40.8 44.8 44.3 0.513
<100 35.6 32.6 29.5
<400 15.5 15.7 12.5
400+ 8.0 7.0 13.6
HS-CTnT detectable (>3 ng/L) (%) 13.9 17.4 19.6 0.072
HS-CTnT concentration if detectable (geom.
mean ng/L± s.d.)
6.7 ±1.8 6.0 ±1.5 6.7 ±2.0 0.578
P values were computed using the likelihood ratio test. All variables were measured at baseline with the exception of response variables
(calculated as the proportional increase from baseline to immediately post task) and ﬁbrinogen recovery (calculated as the proportional
decrease from immediate post task to 45min post task). HS-CTnT was measured at 75min post task. Tertiles of plasma ﬁbrinogen at
baseline (mg/dL): lowest = from 166 to 283; medium= from 284 to 330; highest = from 331 to 573. IQR = interquartile range.
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Table 2 Characteristics of the study sample by tertiles of plasma ﬁbrinogen response to mental stress task (proportional increase
from immediate pre task to immediate post task), for 491 disease-free participants drawn from the Whitehall II epidemiological
cohort between 2006 and 2008 in United Kingdom.
Factor and category Tertiles of plasma ﬁbrinogen response
(proportional increase)
P value
Lowest Medium Highest
Age (mean years± s.d.) 63.2 ±6.0 62.8 ±5.5 62.9 ±5.5 0.279
Male (%) 55.3 53.2 55.0 0.813
Latest grade of employment (%)
Higher 38.8 39.2 38.0 0.383
Intermediate 39.4 36.3 40.9
Lower 21.8 24.6 21.1
Current smoker (%) 5.9 4.7 6.4 0.470
Alcohol consumption (%)
No alcohol 17.6 14.6 15.2 0.832
Below recommended levels 65.9 74.3 73.1
Above recommended levels 16.5 11.1 11.7
Hours of physical activity per week (%)
<1 h 24.6 20.4 25.9 0.793
1—4h 38.3 29.3 28.3
5—7h 19.8 25.1 23.5
>7 h 17.4 25.1 22.3
Body mass index (mean kg/m2 ± s.d.) 26.3 ±3.7 25.7 ±4.3 25.5 ±3.7 0.294
Systolic blood pressure (mean mmHg± s.d.) 129.7 ±15.4 128.8 ±17.6 128.8 ±14.8 0.565
Diastolic blood pressure (mean mmHg± s.d.) 70.7 ±8.6 69.3 ±8.3 69.3 ±9.2 0.157
Glycated haemoglobin (mean %± s.d.) 5.5 ±0.7 5.5 ±0.3 5.4 ±0.4 0.072
Triglycerides (median g/L± IQR) 1.3 ±0.9 1.1 ±0.8 1.2 ±0.8 0.480
HDL (mean mmol/L± s.d.) 1.6 ±0.5 1.7 ±0.4 1.7 ±0.5 0.947
LDL (mean mmol/L± s.d.) 3.1 ±0.9 2.9 ±0.8 3.0 ±0.8 0.253
Total cholesterol (mean mmol/L± s.d.) 5.4 ±1.0 5.2 ±0.8 5.3 ±0.9 0.130
Total cholesterol/HDL ratio (mean± s.d) 3.6 ±1.2 3.2 ±0.9 3.4 ±1.1 0.221
C-reactive protein (median mg/L± IQR) 1.0 ±1.3 1.1 ±1.5 0.9 ±1.2 0.683
Salivary cortisol (mean nmol/L± s.d.) 6.2 ±3.7 6.8 ±4.8 6.3 ±3.7 0.935
IL-6 (median pg/ml± IQR) 1.2 ±0.7 1.1 ±0.9 1.1 ±0.7 0.095
Von Willebrand factor (mean %± s.d.) 105.6 ±39.9 107.4 ±40.0 100.1 ±38.2 0.264
MCP-1 (median pg/mL± IQR) 143.5 ±59.3 138.5 ±57.4 128.7 ±59.4 0.040
Fibrinogen (mean mg/dL± s.d.) 321.6 ±57.6 320.8 ±59.8 302.0 ±65.8 0.001
Salivary cortisol response (mean %
increase± s.d.)
16.1 ±54.2 17.7 ±60.3 14.9 ±65.3 0.711
IL-6 response (mean % increase± s.d.) 40.1 ±60.7 35.1 ±53.5 41.3 ±68.8 0.329
Von Willebrand factor response (mean %
increase± s.d.)
2.8 ±22.2 3.9 ±19.4 8.4 ±19.8 <0.001
MCP-1 response (mean % increase± s.d.) 9.4 ±24.3 5.9 ±19.8 7.7 ±24.0 0.014
Fibrinogen response (mean % increase± s.d.) −1.9 ±5.1 5.0 ±1.4 12.2 ±5.8
Fibrinogen recovery (mean % decrease± s.d.) −1.7 ±10.5 3.2 ±4.6 5.2 ±5.4 <0.001
Agatston coronary calcium score (%)
None 41.2 46.2 43.9 0.340
<100 32.4 31.6 32.7
<400 15.3 12.9 15.8
400+ 11.2 9.4 7.6
HS-CTnT detectable (>3 ng/L) (%) 21.6 19.2 10.5 0.007
HS-CTnT concentration if detectable (geom.
mean ng/L± s.d.)
6.7 ±1.6 6.7 ±2.0 5.5 ±1.5 0.393
P values were computed using the likelihood ratio test. All variables were measured at baseline with the exception of response variables
(calculated as the proportional increase from baseline to immediately post task) and ﬁbrinogen recovery (calculated as the proportional
decrease from immediate post task to 45min post task). HS-CTnT was measured at 75min post task. Tertiles of plasma ﬁbrinogen response
(%): lowest = from −30.5 to 2.6; medium= from 2.7 to 7.4; highest = from 7.4 to 57.6.
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Table 3 Characteristic of the study sample by tertiles of plasma ﬁbrinogen recovery to mental stress task (proportional decrease
from immediate post task to 45min post task), for 491 disease-free participants drawn from the Whitehall II epidemiological
cohort between 2006 and 2008 in United Kingdom.
Factor and category Tertiles of plasma ﬁbrinogen recovery
(proportional decrease)
P value
Lowest Medium Highest
Age (mean years± s.d.) 63.9 ±6.1 62.8 ±5.7 62.3 ±5.1 0.115
Male (%) 51.5 55.6 56.4 0.881
Latest grade of employment (%)
Higher 41.5 39.2 35.5 0.428
Intermediate 39.2 33.9 43.0
Lower 19.3 26.9 21.5
Current smoker (%) 6.4 7.0 3.5 0.085
Alcohol consumption (%)
No alcohol 15.2 17.0 15.7 0.875
Below recommended levels 70.2 72.5 70.3
Above recommended levels 14.6 10.5 14.0
Hours of physical activity per week (%)
<1 h 25.4 23.8 21.2 0.423
1—4h 32.5 33.9 29.1
5—7h 20.1 22.0 26.7
>7 h 21.9 20.2 23.0
Body mass index (mean kg/m2 ± s.d.) 26.0 ±4.1 25.9 ±3.9 25.5 ±3.8 0.357
Systolic blood pressure (mean mmHg± s.d.) 128.6 ±15.2 128.8 ±16.2 129.9 ±16.5 0.934
Diastolic blood pressure (mean mmHg± s.d.) 69.4 ±7.9 69.5 ±8.2 70.3 ±9.9 0.917
Glycated haemoglobin (mean %± s.d.) 5.5 ±0.6 5.5 ±0.4 5.4 ±0.4 0.895
Triglycerides (median g/L± IQR) 1.3 ±0.7 1.2 ±0.8 1.0 ±0.9 0.100
HDL (mean mmol/L± s.d.) 1.7 ±0.5 1.7 ±0.5 1.6 ±0.4 0.325
LDL (mean mmol/L± s.d.) 3.1 ±1.0 2.9 ±0.7 3.0 ±0.8 0.705
Total cholesterol (mean mmol/L± s.d.) 5.4 ±1.0 5.2 ±0.8 5.3 ±0.9 0.142
Total cholesterol/HDL ratio (mean± s.d) 3.5 ±1.2 3.4 ±1.1 3.4 ±1.0 0.825
C-reactive protein (median mg/L± IQR) 1.1 ±1.3 1.1 ±1.6 0.9 ±1.1 0.178
Salivary cortisol (mean nmol/L± s.d.) 6.7 ±4.4 6.5 ±4.4 6.1 ±3.5 0.586
IL-6 (median pg/ml± IQR) 1.2 ±0.8 1.2 ±0.9 1.0 ±0.7 0.206
Von Willebrand factor (mean %± s.d.) 105.8 ±38.0 105.9 ±38.1 101.0 ±42.3 0.230
MCP-1 (median pg/mL± IQR) 145.3 ±55.2 133.5 ±51.8 135.9 ±63.2 0.015
Fibrinogen (mean mg/dL± s.d.) 316.5 ±60.7 323.3 ±63.7 304.6 ±59.6 0.363
Salivary cortisol response (mean %
increase± s.d.)
8.5 ±41.7 17.3 ±66.8 22.9 ±67.3 0.135
IL-6 response (mean % increase± s.d.) 3.2 ±16.1 2.4 ±14.1 0.9 ±12.4 0.011
Von Willebrand factor response (mean %
increase± s.d.)
3.3 ±21.7 5.7 ±24.6 7.1 ±19.8 0.005
MCP-1 response (mean % increase± s.d.) 12.6 ±29.4 6.0 ±18.3 4.3 ±17.8 <0.001
Fibrinogen response (mean % increase± s.d.) 1.6 ±7.5 5.5 ±5.4 8.4 ±7.2 <0.001
Fibrinogen recovery (mean % decrease± s.d.) −5.0 ±8.7 2.9 ±1.4 8.8 ±3.3
Agatston coronary calcium score (%)
None 43.9 45.0 42.4 0.999
<100 31.0 33.9 31.4
<400 16.4 11.1 16.9
400+ 8.8 9.9 9.3
HS-CTnT detectable (>3 ng/L) (%) 20.6 17.6 12.9 0.365
HS-CTnT concentration if detectable (geom.
mean ng/L± s.d.)
5.5 ±1.6 6.7 ±1.8 7.4 ±2.0 0.105
P values were computed using the likelihood ratio test. All variables were measured at baseline with the exception of response variables
(calculated as the proportional increase from baseline to immediately post task) and ﬁbrinogen recovery (calculated as the proportional
decrease from immediate post task to 45min post task). HS-CTnT was measured at 75min post task. Tertiles of plasma ﬁbrinogen recovery
(%): lowest = from −68.5 to 0.3; medium= from 0.4 to 5.2; highest = from 5.2 to 23.1.
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L-6, and vWF. Higher levels of baseline ﬁbrinogen were
lso strongly associated with smaller increases (blunted
esponses) in ﬁbrinogen after the mental stress tasks
P = 0.001) and were marginally associated with positive HS-
TnT values (P = 0.072).
Table 2 shows the correlates of ﬁbrinogen responses
o mental stress tasks. In contrast to baseline, ﬁbrinogen
esponses seemed to be independent from age, gender,
nd most of the other clinical and inﬂammatory covariates.
igher responses to stress were strongly associated with bet-
er recovery (P = 0.001) and with lower chances of testing
ositive for HS-CTnT (P = 0.007).
The correlates of individual differences in post-stress ﬁb-
inogen recovery are shown in Table 3. Fibrinogen recovery
ates appeared to be independent of most covariates, with
he exceptions of MCP-1, IL-6, and vWf, and to be weakly
ssociated with HS-CTnT (P = 0.365).
Table 4 summarizes the results from the logistic regres-
ions on HS-CTnT. The marginally signiﬁcant positive
ssociation between baseline ﬁbrinogen concentration and
S-CTnT was eliminated after the adjustment for covari-
tes. In contrast, the negative association between stress
esponse and detectable HS-CTnT remained very similar to
he crude association in terms of both effect size and statis-
ical signiﬁcance after adjustment for demographic factors,
ardiovascular risk factors, neuroendocrine and inﬂamma-
ory variables, and extent of coronary calciﬁcation: the
dds of detectable HS-CTnT halved for each 10% increase
n ﬁbrinogen response to stress task (odds ratio [OR] = 0.49;
= 0.007; 95% CI = 0.30—0.82).
No pair of covariates had a correlation coefﬁcient >0.30,
ith the following exceptions: systolic and diastolic blood
ressure (0.70); LDL and total cholesterol/HDL ratio (0.62);
riglycerides and total cholesterol/HDL ratio (0.62); CRP and
MI (0.53); CRP and baseline IL-6 (0.45). All covariates had
IFs <3. The exclusion of one or both components of the
entioned pairs of covariates did not change the results. All
ensitivity analyses gave similar results to the main analyses.
The additional analyses involving blood pressure response
nd heart rate response as possible determinants of HS-CTnT
etection, gave null ﬁndings: although systolic blood pres-
ure increased on average by 35.7mmHg (s.d. = 16.0) due
o the stress tests, diastolic blood pressure by 16.8mmHg
s.d. = 7.5), and heart rate by 10.5 (s.d. = 9.2) beats per
inute, the increase in those parameters was not associated
ith positive values of HS-CTnT.
. Discussion
his study conﬁrms prior evidence showing an increase
n plasma ﬁbrinogen in response to mental stress. How-
ver, in contrast with the notion that larger ﬁbrinogen
tress responses may be pathogenic, our results suggest that
reater increases have a physiological protective role for
ardiovascular health such that people with ﬂat morphol-
gy of reaction to mental stress seem to be less protected.
mong the three phases, i.e. basal ﬁbrinogen levels, stress
eactivity, and post-stress recovery, the reactivity seems to
e the more robust marker of allostatic adaptation, showing
ery large effect size, statistical signiﬁcance, and indepen-
ence from covariates.
p
t
cA.I. Lazzarino et al.
We have also shown that a sequence of two brief
oderately challenging mental stress tasks, which are
peciﬁcally designed to mimic mild every-day-life stressors,
an inﬂuence ﬁbrinogen release into the blood stream very
fﬁciently for some individuals and less efﬁciently for oth-
rs, even if they are drawn from a well-deﬁned, low-risk,
isease-free population. It follows that if one-off measure-
ents of plasma ﬁbrinogen are sampled at unspeciﬁed time
oints without taking environmental factors into account
nd, moreover, in individuals from heterogeneous popula-
ions, they would show large intra-individual variation and,
s a consequence, their use as markers of risk may be lim-
ted. Our results therefore explain why some other authors
ave not found robust associations between single mea-
urements of ﬁbrinogen and CVD. For example, Kaptoge
t al. found that ﬁbrinogen was associated with CVD but
as marginally important in predictive models for CVD after
he inclusion of the standard risk factors for CVD prediction
Emerging Risk Factors Collaboration et al., 2012; Stulnig,
013). Similarly, Mendelian randomization studies that were
ocused on the genetic determinants of ﬁbrinogen plasma
oncentration, and not on the reactivity, found no evi-
ence for a causal relationship between ﬁbrinogen levels
nd cardiac disease (Keavney et al., 2006; Ken-Dror et al.,
012).
Thus the novelty of our analysis lies particularly in the
act that we have linked ﬁbrinogen response to laboratory-
nduced acute mental stress with a robust CVD outcome
uch as HS-CTnT. One previous study adopted a very simi-
ar approach but identiﬁed hypertension as the main clinical
utcome and found a positive association between ﬁbrino-
en response and hypertension (Brydon and Steptoe, 2005).
e think that our new ﬁnding is not in contradiction with
his previous study because hypertension is closely associ-
ted with mental stress (Armario et al., 2003) and is a more
istal risk factor for CVD compared to HS-CTnT, which is a
obust proximal marker of CVD.
Allostasis is a convenient framework within which to
xamine the association between mental stress and cardio-
ascular health. Unfortunately, in this study we could not
xplore what the actual causes of altered allostatic proﬁle
re. Stress reactivity seemed to be independent from age,
ender, and other clinical and non-clinical factors related to
VD and to health in general. Also atherosclerosis seemed
ot to interfere with allostatic regulation, although it was
ound that tissue factor (extrinsic coagulation pathway) is
resent in the matrix of the necrotic core of the atheroscle-
otic plaque (Wilcox et al., 1989).
The prevalence of detectable HS-CTnT in our British sam-
le was 17.1%, which is similar to levels reported (15.7%) in
nationally representative CVD-free population sample in
SA (De Lemos et al., 2010).
Detectable HS-CTnT is associated with noncardiac condi-
ions such as severe renal disease (Irfan et al., 2012; Sharma
t al., 2006) and, theoretically, our results could be due to
onfounding if patients with renal disease are more likely to
est positive at mental stress tests. However, it is unlikely
hat this mechanism underlies our results since the study
articipants were free from any chronic conditions at the
ime of testing, as explained in Section 2.
Non-calciﬁed coronary plaques are less detectable using
ardiac computerized tomography and that may partly
Fibrinogen
reactivity
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Table 4 Multiple logistic regression models for the association between baseline ﬁbrinogen, ﬁbrinogen response to mental stress tasks, or ﬁbrinogen recovery and plasma
detectable HS-CTnT, for 491 disease-free participants drawn from the Whitehall II epidemiological cohort between 2006 and 2008 in England.
Model for detectable HS-cTnT (outcome
variable)
Exposure variable
Baseline ﬁbrinogen
(OR for 1 g/L)
Fibrinogen response
(OR for 10% increase)
Fibrinogen recovery
(OR for 10% decrease)
OR (95% CI) P OR (95% CI) P OR (95% CI) P
1. Crude association 1.41 (0.97—2.04) 0.072 0.63 (0.45—0.88) 0.007 0.99 (0.96—1.01) 0.365
2. Adjusted for age, gender, and baseline
ﬁbrinogen when exposure is ﬁbrinogen
response or recovery
1.35 (0.89—2.05) 0.154 0.61 (0.41—0.90) 0.014 0.99 (0.96—1.03) 0.601
3. With further adjustment for latest grade
of employment, smoking, alcohol
consumption, and physical activity
1.27 (0.83—1.95) 0.265 0.61 (0.41—0.91) 0.015 0.99 (0.96—1.03) 0.683
4. With further adjustment for systolic and
diastolic blood pressure, LDL, total
cholesterol/HDL ratio, triglycerides,
glycated haemoglobin, and BMI
1.13 (0.71—1.79) 0.607 0.57 (0.37—0.88) 0.011 0.99 (0.95—1.02) 0.480
5. With further adjustment for baseline
values of CRP, salivary cortisol, IL6,
vWF, and MCP-1
1.05 (0.58—1.91) 0.878 0.53 (0.34—0.83) 0.006 0.98 (0.94—1.02) 0.250
6. With further adjustment for response
values of salivary cortisol, IL6, vWF,
and MCP-1
0.97 (0.50—1.85) 0.919 0.49 (0.30—0.81) 0.006 0.98 (0.94—1.02) 0.284
7. With further adjustment for coronary
calciﬁcation (Agatston score in 4
categories)
0.92 (0.48—1.76) 0.798 0.49 (0.30—0.82) 0.007 0.98 (0.94—1.02) 0.246
All variables were measured at baseline with the exception of response variables (calculated as the proportional increase from baseline to immediately post task) and ﬁbrinogen recovery
(calculated as the proportional decrease from immediate post task to 45min post task). HS-CTnT was measured at 75min post task.
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xplain why CAC did not attenuate the association between
brinogen and HS-CTnT. However, there is a direct rela-
ionship between the number of calciﬁed plaques present
nd total plaque burden, and CAC correlates highly with
he severity of coronary artery disease, so the absence of
alciﬁcation implies that there is probably little signiﬁcant
oronary artery disease (Arad et al., 2000). On the other
and, it has been argued that raised troponin T may be due
o occult or undetected plaque rupture (Korosoglou et al.,
011) and it is known that plaque rupture is a relatively com-
on event that is usually not followed by an acute cardiac
vent (Arbab-Zadeh et al., 2012). This process may have
perated in our patients with minimal CAC score levels and
etectable HS-CTnT. However this is unlikely to invalidate
ur results because atherosclerosis may lie on the causal
athway between ﬁbrinogen and HS-CTnT and also it cannot
ive an alternative explanation to the dynamics of associa-
ion that we found.
Fibrinogen was not associated with CAC in our sam-
le. This may be due to the fact that ﬁbrinogen does not
irectly interfere with the phenomenon of plaque calciﬁ-
ation and/or that ﬁbrinogen and CAC can also operate on
arallel pathways leading to troponin T release.
A single measure of plasma HS-CTnT concentration can-
ot be regarded as a robust test if it is not stable over time,
.e. if it shows high intra-individual short-term variation.
owever, the results from the ARIC study showed that HS-
TnT intra-individual variability over 6 weeks is almost null,
ith a correlation coefﬁcient of 0.94 (Agarwal et al., 2011).
hus, although our study collected HS-CTnT after a brief
oderately stressful behavioural challenge, it is improba-
le that troponin T was released in response to this task.
o the contrary, we hypothesized that higher baseline ﬁb-
inogen is indicative of chronic allostatic load that might
ead to blunted reactivity and impaired recovery, and this
rocess is likely to be relevant to the aetiology of heart dis-
ase, which can be detected by chronic elevation in HS-CTnT
oncentration.
Our study involved participants free of CVD because we
re interested in the primary prevention of heart disease.
his approach has the disadvantage of generating results
hat are not necessarily applicable to the general popula-
ion. Our results could be due to selection bias if people
t the initial stages of the disease or people who already
ad CVD episodes have different patterns of associations
ompared with healthy individuals.
The assay that we have used to measure the concentra-
ion of cardiac troponin T in the peripheral blood plasma had
igh sensitivity but we cannot be sure that the participants
ho scored zero really had no troponin T in their plasma.
lthough the lower detection limit of the assay was very
ow (3 ng/L), some participants may have had lower non-
ero but undetectable concentrations. These measurement
ssues may have distorted our results if such participants
ended to have higher ﬁbrinogen reaction to the mental
tress tests.
This is a cross-sectional study and therefore we cannot
etermine the causal sequence. Blunted ﬁbrinogen stress
esponsivity may contribute to early signs of CVD, or people
t an early stage of cardiac disease may be more prone to
isturbed stress responses. In fact, cardiac troponins are the
ost sensitive and speciﬁc biochemical markers of myocar-
T
U
tA.I. Lazzarino et al.
ial damage (Jaffe et al., 2000), but their elevation can be
ue to a variety of reasons such as pericarditis, myocardi-
is, and pulmonary embolism (Roongsritong et al., 2004).
owever, it is unlikely that the undetected presence of
hose conditions can explain our ﬁndings since no partici-
ants reported any symptoms or signs of cardiac or kidney
isease, had any previous diagnosis or treatment for hyper-
ension, inﬂammatory disease or allergies, and did not show
ny electrocardiographic indications of cardiac disease on
ests carried out over more than 20 years in the Whitehall II
tudy.
The role of ﬁbrinogen in the coagulation cascade is com-
lex because ﬁbrinogen is not only the product but also the
rigin of several reactions within a system of mutually rein-
orcing and mutually rebalancing agents. For example, the
reakdown of ﬁbrinogen has a pro-haemostatic function on
he one hand, given that this phenomenon is the only route
or the formation of ﬁbrin, and has an anti-haemostatic func-
ion on the other hand, since unbroken ﬁbrinogen induces
latelet adhesion and activation (Chiumiento et al., 2007;
amath and Lip, 2003). In our study, for some people ﬁb-
inogen levels increased by more than 10% after a brief
tress test and it is plausible that the released ﬁbrinogen
ame from activated platelets rather than from liver pro-
uction, which can take several hours to be completed. In
act, platelets exhibit both adrenergic and dopaminergic
eceptors that are inﬂuenced by different catecholamines
nd it has been shown that physiological and pathological
onditions causing sympathoadrenal activation in vivo, e.g.
ental stress, modify the circulating platelet populations
nd modulate platelet reactivity through an increase in cir-
ulating catecholamines (Anfossi and Trovati, 1996).
The fact that heart rate response and blood pressure
esponse were not associated with detectable plasma lev-
ls of HS-CTnT suggests that the stress response dynamics
eading to heart disease may be peculiar for some CVD risk
actors only.
In conclusion, greater ﬁbrinogen responses to mental
tress are associated with lower likelihood of detectable
igh-sensitivity troponin T plasma concentration, indepen-
ently of basal ﬁbrinogen. Thus, a more dynamic ﬁbrinogen
esponse appears to be advantageous for cardiovascular
ealth. Further research is needed to ascertain the role of
brinogen in the pathophysiology of cardiovascular disease
nd the causes of impaired allostatic adaptation to mental
tress.
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